RxDoctor Payments DataLook up a doctor →

Timothy Livingston

Neurology with Special Qualifications in Child Neurology · Nashville, TNNPI 1093751471

Payments from drug & device makers

$13,611in general payments, 2019–2025

Across 558 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$2K
  • Neurelis, Inc.$2K
  • Supernus Pharmaceuticals, Inc.$1K
  • Livanova USA, Inc.$981
  • SK Life Science, Inc.$858
  • Aquestive Therapeutics, Inc.$691
  • plus $6K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.70$2,252
Neurelis, Inc.63$1,540
Supernus Pharmaceuticals, Inc.87$1,002
Livanova USA, Inc.6$981
SK Life Science, Inc.39$858
Aquestive Therapeutics, Inc.39$691
Sunovion Pharmaceuticals Inc.51$648
Jazz Pharmaceuticals Inc.14$525
Greenwich Biosciences, Inc.15$509
Corium, LLC19$507
Acadia Pharmaceuticals Inc16$471
Immedica Pharma US, Inc.10$463
Eisai Inc.18$407
Biogen15$331
Tris Pharma Inc12$242
Sumitomo Pharma America, Inc.10$240
Catalyst Pharmaceuticals, Inc.8$213
Mallinckrodt Enterprises LLC5$174
Ironshore Pharmaceuticals Inc.6$162
Intrabio Inc2$152
Azurity Pharmaceuticals, Inc.7$150
Aucta Pharmaceuticals, Inc.7$130
Springworks Therapeutics, Inc.5$123
Biomarin Pharmaceutical Inc.3$121
Zogenix Inc.2$64
Sobi, Inc2$57
Agios Pharmaceuticals, Inc.2$52
Novartis3$48
Collegium Pharmaceutical, Inc.2$43
Travere Therapeutics, Inc.2$37
ITF Therapeutics LLC2$36
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)1$34
Ultragenyx Pharmaceutical Inc.1$32
Takeda Pharmaceuticals U.S.A., Inc.2$32
Sanofi1$31
Mesoblast, Inc.1$30
Ipsen Biopharmaceuticals, Inc1$28
Avion Pharmaceuticals1$26
Upsher-smith Laboratories LLC1$25
Y-mabs Therapeutics, Inc.1$25
Syndax Pharmaceuticals, Inc.1$23
Pyros Pharmaceuticals, Inc.1$21
PTC Therapeutics, Inc.1$21
Amneal Pharmaceuticals LLC1$20
Mirum Pharmaceuticals, Inc.1$18
Soleno Therapeutics, Inc.1$17

How this compares

$13,611 in reported general payments places this provider in the 65th percentile of 47 neurology with special qualifications in child neurology providers in Tennessee.

See all neurology with special qualifications in child neurology providers in Tennessee →

Other neurology with special qualifications in child neurology in Nashville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →